Vivanza Biosciences Ltd — Important, 12-02-2026: Company Update

Vivanza Biosciences confirmed it has not raised any new funds through public, rights, or preferential issues. Consequently, the company is exempt from submitting a statement on any deviations or variations in the use of such fund proceeds, as this reporting requirement does not apply to them. This update reflects the company's current compliance status regarding capital raising activities and assures investors of routine regulatory adherence without recent dilutive equity financing.